File a 30-day mdr.An assessment was conducted.The event is still considered reportable under fda's regulation.Submission for due diligence: the patient presents with a non-treatment-requiring dry cough.Following a clinical investigation, the patient discloses pulmonary scarring diagnosed through a ct scan.The etiology of the scarring remains unidentified, and the dry cough is progressively resolving.Notably, the medical transcript does not attribute the scarring to the use of soclean, and it is pertinent to acknowledge the patient's history of tobacco product consumption as a plausible contributor to the observed pulmonary scarring.
|